Total cholesterol and cancer risk in a large prospective study in Korea
dc.contributor.author | Kitahara, C. | |
dc.contributor.author | De González, A. | |
dc.contributor.author | Freedman, N. | |
dc.contributor.author | Huxley, Rachel | |
dc.contributor.author | Mok, Y. | |
dc.contributor.author | Jee, S. | |
dc.contributor.author | Samet, J. | |
dc.date.accessioned | 2017-01-30T11:16:19Z | |
dc.date.available | 2017-01-30T11:16:19Z | |
dc.date.created | 2016-02-04T19:30:30Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Kitahara, C. and De González, A. and Freedman, N. and Huxley, R. and Mok, Y. and Jee, S. and Samet, J. 2011. Total cholesterol and cancer risk in a large prospective study in Korea. Journal of Clinical Oncology. 29 (12): pp. 1592-1598. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/10016 | |
dc.identifier.doi | 10.1200/JCO.2010.31.5200 | |
dc.description.abstract |
Purpose: To further clarify the relationship between total cholesterol and cancer, which remains unclear. Methods: We prospectively examined the association between total cholesterol and site-specific and all-cancer incidence among 1,189,719 Korean adults enrolled in the National Health Insurance Corporation who underwent a standardized biennial medical examination in 1992 to 1995 and were observed for 14 years until cancer diagnosis or death.Results: Over follow-up, 53,944 men and 24,475 women were diagnosed with a primary cancer. Compared with levels less than 160 mg/dL, high total cholesterol (≥ 240 mg/dL) was positively associated with prostate cancer (hazard ratio [HR], 1.24; 95% CI, 1.07 to 1.44; P trend = .001) and colon cancer (HR, 1.12; 95% CI, 1.00 to 1.25; P trend = .05) in men and breast cancer in women (HR, 1.17; 95% CI, 1.03 to 1.33; P trend = .03). Higher total cholesterol was associated with a lower incidence of liver cancer (men: HR, 0.42; 95% CI, 0.38 to 0.45; P trend < .001; women: HR, 0.32; 95% CI, 0.27 to 0.39; P trend < .001), stomach cancer (men: HR, 0.87; 95% CI, 0.82 to 0.93; P trend ≤ .001; women: HR, 0.86; 95% CI, 0.77 to 0.97; P trend = .06), and, in men, lung cancer (HR, 0.89; 95% CI, 0.82 to 0.96; P trend < .001).Results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis B surface antigen status (men: HR, 0.60; P trend < .001; women: HR, 0.46; P trend = .003) and exclusion of the first 10 years of follow-up (men: HR, 0.59; P trend < .001; women: HR, 0.44; P trend < .001). Total cholesterol was inversely associated with all-cancer incidence in both men (HR, 0.84; 95% CI, 0.81 to 0.86; P trend < .001) and women (HR, 0.91; 95% CI, 0.87 to 0.95; P trend < .001), but these associations were attenuated after excluding incident liver cancers (men: HR, 0.95; P trend < .001; women: HR, 0.98; P trend = .32). Conclusion: In this large prospective study, we found that total cholesterol was associated with the risk of several different cancers, although these relationships differed markedly by cancer site. | |
dc.title | Total cholesterol and cancer risk in a large prospective study in Korea | |
dc.type | Journal Article | |
dcterms.source.volume | 29 | |
dcterms.source.number | 12 | |
dcterms.source.startPage | 1592 | |
dcterms.source.endPage | 1598 | |
dcterms.source.issn | 0732-183X | |
dcterms.source.title | Journal of Clinical Oncology | |
curtin.department | School of Public Health | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |